Jabbour, S. A., Frías, J. P., Guja, C., Hardy, E., Ahmed, A., & Öhman, P. (2018). Effects of exenatide once weekly plus dapagliflozin, exenatide once weekly, or dapagliflozin, added to metformin monotherapy, on body weight, systolic blood pressure, and triglycerides in patients with type 2 diabetes in the DURATION‐8 study. Diabetes Obes Metab.
Stile di citazione ChicagoJabbour, Serge A., Juan P. Frías, Cristian Guja, Elise Hardy, Azazuddin Ahmed, e Peter Öhman. "Effects of Exenatide Once Weekly Plus Dapagliflozin, Exenatide Once Weekly, or Dapagliflozin, Added to Metformin Monotherapy, On Body Weight, Systolic Blood Pressure, and Triglycerides in Patients With Type 2 Diabetes in the DURATION‐8 Study." Diabetes Obes Metab 2018.
Citazione MLAJabbour, Serge A., et al. "Effects of Exenatide Once Weekly Plus Dapagliflozin, Exenatide Once Weekly, or Dapagliflozin, Added to Metformin Monotherapy, On Body Weight, Systolic Blood Pressure, and Triglycerides in Patients With Type 2 Diabetes in the DURATION‐8 Study." Diabetes Obes Metab 2018.